Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study

Detalles Bibliográficos
Autores principales: Buti, Sebastiano, Donini, Maddalena, Bersanelli, Melissa, Gattara, Alessia, Leonardi, Francesco, Passalacqua, Rodolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995793/
https://www.ncbi.nlm.nih.gov/pubmed/29808389
http://dx.doi.org/10.1007/s40268-018-0234-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995793/
https://www.ncbi.nlm.nih.gov/pubmed/29808389
http://dx.doi.org/10.1007/s40268-018-0234-z

Ejemplares similares